newsfilter
← Latest News
PR Newswire·

Medivir to present at the Redeye Orphan Drugs Conference

STOCKHOLM, April 25, 2022 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Redeye Orphan Drugs Conference on April 27, 2022. CEO Jens Lindberg will present at 15.15 CET. The presentation is live